OPKO’s BioReference Laboratories Selected for UnitedHealthcare’s Preferred Lab Network

ELMWOOD PARK, NJ, April 22, 2019 – BioReference Laboratories Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it will gain preferred laboratory network provider status for UnitedHealthcare. The contract includes BioReference’s subsidiary GeneDx, a full service genetics laboratory.  Learn about the UnitedHealthcare Preferred Lab Network here.

“At BioReference we are committed to making the laboratory experience cost effective, timely and accurate, from the time the provider orders the test to the delivery of the results to the patient. We are very excited about the opportunity to enhance that commitment to UnitedHealthcare members by becoming part of the Preferred Lab Network,” said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories.

The new agreement is effective July 1, 2019.